CANTAB Trademark
Trademark Overview
On Friday, May 22, 1992, a trademark application was filed for CANTAB with the United States Patent and Trademark Office. The USPTO has given the CANTAB trademark a serial number of 74277845. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Friday, September 6, 1996. This trademark is owned by CANTAB PHARMACEUTICALS PLC. The CANTAB trademark is filed in the Pharmaceutical Products category with the following description:
finished pharmaceutical products for the prevention and treatment of human and animal diseases which modulate, activate or suppress the human or animal immune system, specifically restricted to products for the prevention or treatment of autoimmune diseases (rheumatoid arthritis, myasthenia gravis, systemic lupus erythematous, multiple sclerosis), inflammatory diseases (psoriasis, Crohn's disease, ulcerative colitis, asthma, allergic reactions), benign and malignant tumors (genital condylomata and cervical cancer), viral diseases (herpes virus diseases such as oral herpes (HSV 1), genital herpes (HSV 1/2), chicken pox/shingles (varicella zoster virus), cytomegalovirus; respiratory syncytial viruses; measles viruses; human immunodeficiency viruses), microbial and parasitic infections, septic or trauma induced shock and organ transplant rejection
General Information
| Serial Number | 74277845 |
| Word Mark | CANTAB |
| Filing Date | Friday, May 22, 1992 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Friday, September 6, 1996 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 1000 - Typeset: Word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, May 4, 1993 |
Trademark Statements
| Goods and Services | finished pharmaceutical products for the prevention and treatment of human and animal diseases which modulate, activate or suppress the human or animal immune system, specifically restricted to products for the prevention or treatment of autoimmune diseases (rheumatoid arthritis, myasthenia gravis, systemic lupus erythematous, multiple sclerosis), inflammatory diseases (psoriasis, Crohn's disease, ulcerative colitis, asthma, allergic reactions), benign and malignant tumors (genital condylomata and cervical cancer), viral diseases (herpes virus diseases such as oral herpes (HSV 1), genital herpes (HSV 1/2), chicken pox/shingles (varicella zoster virus), cytomegalovirus; respiratory syncytial viruses; measles viruses; human immunodeficiency viruses), microbial and parasitic infections, septic or trauma induced shock and organ transplant rejection |
| Pseudo Mark | CAN TAB |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 8 - Abandoned |
| Class Status Date | Wednesday, August 4, 1999 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | CANTAB PHARMACEUTICALS PLC |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | Cambridge CB4 4GN |
| Party Name | CANTAB PHARMACEUTICALS PLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Cambridge CB4 4GN |
Trademark Events
| Event Date | Event Description |
| Friday, September 6, 1996 | ABANDONMENT - NO USE STATEMENT FILED |
| Tuesday, March 5, 1996 | NOA MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, May 4, 1993 | PUBLISHED FOR OPPOSITION |
| Friday, April 2, 1993 | NOTICE OF PUBLICATION |
| Tuesday, March 2, 1993 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, February 19, 1993 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, August 19, 1992 | NON-FINAL ACTION MAILED |
| Tuesday, August 4, 1992 | ASSIGNED TO EXAMINER |
